RAINFOL-03 | NCT07166094

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer. Contact: RAINFOL-03@anzgog.org.au

RAINFOL-03 | NCT071660942026-07-09T06:49:18+10:00

RAINFOL-02 | NCT06619236

Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Platinum Resistant Ovarian Cancer. Contact: RAINFOL-02@anzgog.org.au

RAINFOL-02 | NCT066192362026-07-09T06:49:42+10:00

RAMP-301 | NCT06072781

The RAMP-301 trial will assess the safety and efficacy of the combination of Avutometinib plus Defactinib versus Investigator’s Choice of Treatment options (ICT) in patients with recurrent Low-grade Serous Ovarian Cancer (LGSOC) who have progressed on a prior platinum-based [...]

RAMP-301 | NCT060727812026-07-09T06:49:30+10:00
Go to Top